Clinical Trial

UBT251 Injection Phase II Study (Overweight or Obesity)

Name: UBT251 Injection Phase II Study (Overweight or Obesity) — clinical trial record (NCT07177469)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 2

View on ClinicalTrials.gov →

Summary

This randomized, double-blind, parallel, placebo-controlled phase II study to evaluate the efficacy and safety of UBT251 Injection in overweight/obese patients

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-16.

Status change: Active, Not Recruiting → Completed 2026-05-06

Trial Details

NCT Number	NCT07177469
Lead Sponsor	The United Bio-Technology (Hengqin) Co., Ltd.
Conditions	Obesity & Overweight
Enrollment	205 participants
Start Date	2025-03-14
Primary Completion	2025-10-22 (estimated)
Study Completion	2025-11-19 (estimated)
Updated on ClinicalTrials.gov	2026-05-07